Toh bhaiyo aur behno, Sastasundar Ventures ne apne consolidated results mein kamaal kar dikhaya hai! Q3 FY26 mein company ₹35.87 Lakhs ka consolidated Net Profit le aayi hai. Yaad hai pichhle saal isi quarter mein yeh log ₹4,002.52 Lakhs ke loss mein the? Aur uske pehle wale quarter (Q2 FY26) mein bhi ₹1,543.93 Lakhs ka loss tha! Is itne bade turnaround ka sabse bada reason pata hai kya hai? Exceptional items mein aaya hua zabardast positive swing!
Pichhle saal ke nine months mein toh ₹19,090.91 Lakhs ka exceptional loss tha, aur abhi is quarter mein exceptional items ka impact ₹16.61 Lakhs ka hi kuch khaas nahi hai. Aur revenue ki baat karein toh, woh bhi badha hai! Consolidated revenue 23% saal-dar-saal badh kar ₹34,573.70 Lakhs ho gaya hai. Agar pichhle quarter se compare karein toh 14.7% ka growth hai, matlab ₹30,132.06 Lakhs se ₹34,573.70 Lakhs tak pahunch gaya.
Ab agar nine months (9MFY26) ki baat karein, toh yahaan bhi chamatkar dikh raha hai. Consolidated Net Profit ₹1,152.15 Lakhs raha, jo ki pichhle saal ke ₹14,031.11 Lakhs ke loss se ekdum ulta hai. Revenue bhi 14.5% badh kar ₹94,548.58 Lakhs ho gaya hai.
Lekin, bhai, sab kuch itna bhi achha nahi hai. Jab standalone results dekhte hain na, toh picture thodi kharab lagti hai. Sastasundar Ventures ka standalone Net Loss Q3 FY26 mein badh kar ₹40.99 Lakhs ho gaya hai, jo pichhle saal ₹10.49 Lakhs tha. Standalone revenue bhi ₹9.46 Lakhs se gir kar ₹10.72 Lakhs ho gaya. Aur nine months ka standalone loss toh ₹79.92 Lakhs ho gaya hai, jo pichhle saal ₹64.54 Lakhs tha.
Ab sabse badi chinta ki baat suno. Company ne ek step-down subsidiary, Genu Path Labs Limited, ke liye 'Material Uncertainty Relating to Going Concern' mention kiya hai. Matlab, unki financial condition itni kharab hai ki woh future mein apna kaam chala payenge ya nahi, yeh clear nahi hai. Unki current liabilities, assets se zyada hain, aur net worth bhi kam ho gaya hai. Company ka support hai, par yeh risk toh hai hi.
Aur yeh jo consolidated profit mein turnaround dikh raha hai na, woh basically exceptional items ki wajah se hai, jaise ki ek investment ko liquidate karne se hua bada loss recover hua. Matlab, core business se itna bada profit nahi hai. Company ne apni subsidiary, Sastasundar Healthbuddy Limited (SHBL) mein buy-back bhi complete kiya hai, jisse unka stake 78.89% ho gaya hai. Aur Happymate Foods Limited ko bhi bech diya hai. Lekin sabse disappointing baat yeh hai ki management ne koi future outlook ya guidance nahi diya hai, matlab aage kya hone wala hai, iska koi idea nahi.